Laura Bosworth is CEO and co-founder of TeVido BioDevices. Ms. Bosworth is a dynamic former Fortune 50 executive with over 25 years of cross-functional industry experience. With over 18 years in product, process and service development at both the engineering and marketing level, she has experience launching new business start-ups within a larger corporation. She has led numerous successful strategy efforts.
Ms. Bosworth has served with several applied entrepreneurship programs, mentoring aspiring entrepreneurs to develop their own high-growth (more than a $1 Million) companies. Ms. Bosworth has served on UTEP’s College of Engineering Advisory Board and in 2010, she led a task force that recommended a strategy to create a culture of innovation and entrepreneurship and is now involved in its implementation.
With a B.S. in Metallurgical Engineering from the University of Texas at El Paso she started her career in manufacturing process development for IBM Austin. She quickly moved into management where she led custom software development projects and launched a Technical Marketing Center earning a General Manager’s Award for her contributions to sales. At Dell, she led organizations in building strategic business partnerships, software product marketing and created multiple technical sales support functions: enabling over $500M in sales. She launched a professional services business unit and has expertise in customer support services. Using her cross-functional and international experience, she developed corporate wide strategies that reduced operating costs by ~$120M and improved customer satisfaction by 40-50%.
Dr. Thomas Boland, Chief Science Officer and co-founder of TeVido BioDevices currently holds, in association with Clemson University, a US Patent, issued in 2006, with broad claims for inkjet tissue printing. Live-cell tissue printing has been his primary field of research for over 10 years and he has received over $8M in research funding for his work. Dr. Boland’s work has been cited more than 800 times. He’s received numerous awards and was featured on CNN and the Discovery Channel for his groundbreaking research using inkjet printers to assemble cells and biomaterials into viable and functioning structures. As Chief Science Officer for TeVido, Dr. Boland oversees research and technical process development. He is also the Director of Biomedical Engineering at the University of Texas at El Paso (UTEP).
Dr. Scott Collins, Chief Technology Officer and VP of Research and Development at TeVido BioDevices, is an accomplished leader with 23 years expertise spanning engineering, the life sciences, biodevices, corporate strategy, operations, design, and consulting including 14 years of proven leadership experience spanning all aspects of forming, growing and selling a technology company.
At Arrhythmia Research Technology he led internal engineering development and designed a biological data acquisition system that analyzed electrophysiological signals in real time. The system was launched and used by cardiologists in the research market. Next, Collins designed a portable acquisition system that spanned the research and clinical markets, providing a way for clinicians to move their research to the bedside quicker in a way similar to what later became the iPhone / apps store in the consumer market.
Subsequently, Dr. Collins formed and grew a business in the IT space that advised companies on how to utilize technology effectively to meet business objectives. He successfully exited this business to pursue a PhD in Biomedical Engineering, where he set up two state of the art stem cell and tissue engineering labs, developed imaging protocols for complex 3D cell cultures and created or enhanced several protocols related to de novo microvascular channel formation–fundamental to the fields of tissue engineering and regenerative medicine.